ANRO STOCK NEWS: Alto Neuroscience, Inc. Investors are Reminded of the Pending Lead Plaintiff Deadline; Contact Robbins LLP for Information on Leading the Class Action

SAN DIEGO, Sept. 2, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired (a) Alto Neuroscience, Inc. (NYSE: ANRO) common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering ("IPO") conducted on or about February 2, 2024, and/or (b) Alto securities between February 2, 2024 and October 22, 2024. Alto operates as a clinical-stage biopharmaceutical compa ...